verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler zydus lifesciences limited
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1601
Product ID 70771-1601_f1081c30-3025-42ce-b222-824630689bb8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214215
Listing Expiration 2026-12-31
Marketing Start 2020-10-22

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711601
Hyphenated Format 70771-1601

Supplemental Identifiers

RxCUI
898316 1665057
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA214215 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 25 CARTON in 1 CARTON (70771-1601-7) / 5 VIAL in 1 CARTON (70771-1601-5) / 2 mL in 1 VIAL (70771-1601-1)
source: ndc

Packages (1)

70771-1601-7 25 CARTON in 1 CARTON (70771-1601-7) / 5 VIAL in 1 CARTON (70771-1601-5) / 2 mL in 1 VIAL (70771-1601-1)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f1081c30-3025-42ce-b222-824630689bb8", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["898316", "1665057"], "spl_set_id": ["cccf4a5f-6c5d-4d52-97e4-fe7a2dbd28d8"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 CARTON in 1 CARTON (70771-1601-7)  / 5 VIAL in 1 CARTON (70771-1601-5)  / 2 mL in 1 VIAL (70771-1601-1)", "package_ndc": "70771-1601-7", "marketing_start_date": "20201022"}], "brand_name": "Verapamil Hydrochloride", "product_id": "70771-1601_f1081c30-3025-42ce-b222-824630689bb8", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70771-1601", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA214215", "marketing_category": "ANDA", "marketing_start_date": "20201022", "listing_expiration_date": "20261231"}